Sumatriptan and Naproxen Sodium
- Product NDC
- 71800-901
- 11-digit product format
- 718000901
- Labeler code
- 71800
- Product ID
- 71800-901_19d5024a-b131-41c3-8cee-5e20564154aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Sumatriptan and Naproxen Sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Innovida Phamaceutique Corporation
- Application
- ANDA202803
- Marketing category
- ANDA
- Marketing start
- 2020-12-09
- Marketing end
- 0000-00-00
- Substance
- SUMATRIPTAN SUCCINATE; NAPROXEN SODIUM
- Active strength
- 85 mg/1; mg/1
- Pharmacologic classes
- Serotonin 1d Receptor Agonists [MoA],Serotonin-1b and Serotonin-1d Receptor Agonist [EPC],Serotonin 1b Receptor Agonists [MoA],Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71800-901-01 | 71800090101 | 9 TABLET, FILM COATED in 1 BOTTLE (71800-901-01) | 2020-12-09 | 0000-00-00 | No | No | Current |